Active ingredient
Bortezomib
33 finished FDA listings contain Bortezomib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- BORTEZOMIB
- Dosage forms
- Injection, Injection, Powder, Lyophilized, For Solution
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 26
- Strengths listed
- 1 mg/1 · 1 mg/ml · 2.5 mg/1 · 3.5 mg/1 · 3.5 mg/1.4ml · 3.5 mg/3.5ml
- Brand names in FDA listings
- Boruzu, Velcade
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 358258
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 021602 | TAKEDA PHARMS USA | 2003-05-13 | 1 |
| ANDA 209659 | FRESENIUS KABI USA | 2022-05-02 | 1 |
| ANDA 208392 | PHARMASCIENCE INC | 2022-05-02 | 1 |
| NDA 209191 | HOSPIRA | 2022-05-02 | 2 |
| ANDA 210204 | ZYDUS PHARMS | 2022-05-02 | 2 |
| ANDA 205533 | APOTEX | 2022-05-02 | 1 |
| ANDA 210824 | QILU PHARM HAINAN | 2022-05-02 | 3 |
| ANDA 212825 | EUGIA PHARMA | 2022-05-02 | 2 |
| ANDA 215011 | JIANGSU HANSOH PHARM | 2022-07-26 | 1 |
| ANDA 209622 | MSN | 2022-07-26 | 3 |
| ANDA 202963 | DR REDDYS | 2022-07-26 | 2 |
| ANDA 212958 | MEITHEAL | 2022-07-26 | 2 |
| ANDA 208460 | HOSPIRA | 2022-07-26 | 1 |
| NDA 215331 | MAIA PHARMS INC | 2022-07-27 | 2 |
| ANDA 211898 | RELIANCE LIFE SCI | 2022-10-11 | 2 |
| ANDA 212204 | HETERO LABS LTD VI | 2024-05-03 | 1 |
| NDA 212782 | SHILPA | 2024-08-26 | 2 |
| ANDA 216528 | SHUANGCHENG | 2025-12-17 | 2 |
| ANDA 219167 | GLAND | 2026-01-06 | 2 |
Official labeling on DailyMed
- BORTEZOMIB (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP ] · version 7 · 2026-09-10
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AVENACY, LLC] · version 1 · 2026-05-01
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GLAND PHARMA LIMITED] · version 4 · 2026-01-12
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NINGBO SHUANGCHENG PHARMACEUTICAL CO., LTD.] · version 3 · 2025-12-31
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EUGIA US LLC] · version 1 · 2025-12-25
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BLUEPOINT LABORATORIES] · version 5 · 2025-11-21
- VELCADE (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.] · version 36 · 2025-09-01
- BORUZU (BORTEZOMIB) INJECTION [AMNEAL PHARMACEUTICALS LLC] · version 2 · 2025-08-08
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BLUEPOINT LABORATORIES] · version 2 · 2025-08-04
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] · version 6 · 2025-07-28
- BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] · version 1 · 2025-05-22
- BORTEZOMIB (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SOMERSET THERAPEUTICS LLC] · version 1 · 2025-05-12
Showing the 12 most recent of 30 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.